{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:04:14Z","timestamp":1794647054474,"version":"4.9.1"},"reference-count":146,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.heliyon.2023.e15347","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:54:57Z","timestamp":1681088097000},"page":"e15347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Therapeutic potential of bioactive phytoconstituents found in fruits in the treatment of non-alcoholic fatty liver disease: A comprehensive review"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9182-7948","authenticated-orcid":false,"given":"Manash Pratim","family":"Pathak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1421-8962","authenticated-orcid":false,"given":"Kalyani","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Saikia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urvashee","family":"Gogoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pompy","family":"Patowary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pronobesh","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparoop","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e15347_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2023.e15347_bib2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/microorganisms9050957","article-title":"Gut microbiota and NAFLD: pathogenetic mechanisms, microbiota signatures, and therapeutic interventions","volume":"9","author":"Hrncir","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.heliyon.2023.e15347_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12664-010-0069-1","article-title":"Nonalcoholic fatty liver disease in India \u2013 a lot done, yet more required","volume":"29","author":"Duseja","year":"2010","journal-title":"Indian J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib4","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2023.e15347_bib5","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e15347_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2023.e15347_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: an expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.00361","article-title":"Advances in the involvement of gut microbiota in pathophysiology of NAFLD","volume":"7","author":"Jiang","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.heliyon.2023.e15347_bib9","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.3390\/ijms21155214","article-title":"Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications","volume":"21","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e15347_bib10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jhep.2016.06.010","article-title":"Destined to develop NAFLD? The predictors of fatty liver from birth to adulthood","volume":"65","author":"Valenti","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ng.3855","article-title":"Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci","volume":"49","author":"Stender","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.heliyon.2023.e15347_bib13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jhep.2021.12.024","article-title":"Metabolic and genetic contributions to NAFLD: really distinct and homogeneous?","volume":"76","author":"Speliotes","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2016.05.020","article-title":"Childhood predictors of adult fatty liver. The cardiovascular risk in young Finns study","volume":"65","author":"Suomela","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/hep.29833","article-title":"Expression of microRNA-155 in inflammatory cells modulates liver injury","volume":"68","author":"Blaya","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2023.e15347_bib16","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.clinthera.2021.01.021","article-title":"Therapy for nonalcoholic fatty liver disease: current options and future directions","volume":"43","author":"Campbell","year":"2021","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.heliyon.2023.e15347_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.24747","article-title":"A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis","volume":"55","author":"Ratziu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2023.e15347_bib18","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/hep.26461","article-title":"Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"58","author":"Staels","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2023.e15347_bib19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2009.03.025","article-title":"Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis","volume":"51","author":"Zhang","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/jech-2020-214568","article-title":"Fruit and vegetable consumption and non-alcoholic fatty liver disease among Korean adults: a prospective cohort study","author":"Kim","year":"2020","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.heliyon.2023.e15347_bib21","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI6223","article-title":"Peroxisome proliferator-activated receptor \u03b1 mediates the adaptive response to fasting","volume":"103","author":"Kersten","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2023.e15347_bib22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/ajcn\/81.1.122","article-title":"Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men","volume":"81","author":"Nagao","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.heliyon.2023.e15347_bib23","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.ijo.0802141","article-title":"Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver","volume":"26","author":"Murase","year":"2002","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.heliyon.2023.e15347_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110758","article-title":"Protective role of plant sterol and stanol esters in liver inflammation: insights from mice and humans","volume":"9","author":"Plat","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e15347_bib25","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.bbalip.2018.08.004","article-title":"Intake of stigmasterol and \u03b2-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet","volume":"1863","author":"Feng","year":"2018","journal-title":"Biochim. Biophys. Acta, Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.heliyon.2023.e15347_bib26","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1039\/C9FO01570A","article-title":"The regulatory effects of phytosterol esters (PSEs) on gut flora and faecal metabolites in rats with NAFLD","volume":"11","author":"Song","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.heliyon.2023.e15347_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.611323","article-title":"Resveratrol improves liver steatosis and insulin resistance in non-alcoholic fatty liver disease in association with the gut microbiota","volume":"12","author":"Du","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib28","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.nutres.2014.07.010","article-title":"Carotenoids, inflammation, and oxidative stress-implications of cellular signaling pathways and relation to chronic disease prevention","volume":"34","author":"Kaulmann","year":"2014","journal-title":"Nutr. Res."},{"key":"10.1016\/j.heliyon.2023.e15347_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.phrs.2007.01.012","article-title":"Carotenoids and human health","volume":"55","author":"Rao","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2023.e15347_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3961\/jpmph.2008.41.1.39","article-title":"Associations of non alcoholic fatty liver with the metabolic syndrome and serum carotenoids","volume":"41","author":"Park","year":"2008","journal-title":"J. Prev. Med. Public Health."},{"key":"10.1016\/j.heliyon.2023.e15347_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.molmet.2018.11.001","article-title":"Tannic acid, a novel histone acetyltransferase inhibitor, prevents non-alcoholic fatty liver disease both in vivo and in vitro model","volume":"19","author":"Chung","year":"2019","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib32","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.molmet.2017.10.003","article-title":"A polyphenol-rich cranberry extract reverses insulin resistance and hepatic steatosis independently of body weight loss","volume":"6","author":"Anh\u00ea","year":"2017","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150913","article-title":"Raphanus sativus cv. Sango sprout juice decreases diet-induced obesity in sprague dawley rats and ameliorates related disorders","volume":"11","author":"Vivarelli","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e15347_bib34","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.nutres.2016.01.011","article-title":"Mulberry ethanol extract attenuates hepatic steatosis and insulin resistance in high-fat diet-fed mice","volume":"36","author":"Song","year":"2016","journal-title":"Nutr. Res."},{"key":"10.1016\/j.heliyon.2023.e15347_bib35","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/nu11030494","article-title":"Lonicera caerulea extract attenuates non-alcoholic fatty liver disease in free fatty acid-induced HepG2 hepatocytes and in high fat diet-fed mice","volume":"11","author":"Park","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2023.e15347_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1248\/bpb.b18-00702","article-title":"Preventive effect of citrus aurantium peel extract on high-fat diet-induced non-alcoholic fatty liver in mice","volume":"42","author":"Han","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.heliyon.2023.e15347_bib37","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3390\/nu10111719","article-title":"Ursolic acid attenuates hepatic steatosis, fibrosis, and insulin resistance by modulating the circadian rhythm pathway in diet-induced obese mice","volume":"10","author":"Kwon","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2023.e15347_bib38","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2337\/db09-0634","article-title":"Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance","volume":"58","author":"Mulvihill","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.heliyon.2023.e15347_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7420265","article-title":"Nobiletin inhibits hepatic lipogenesis via activation of AMP-activated protein kinase","volume":"2018","author":"Yuk","year":"2018","journal-title":"Evid. Based Complementary Altern. Med."},{"key":"10.1016\/j.heliyon.2023.e15347_bib40","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.clinre.2011.04.015","article-title":"Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role","volume":"35","author":"Aubert","year":"2011","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib41","doi-asserted-by":"crossref","first-page":"9887","DOI":"10.1074\/jbc.M410310200","article-title":"Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling","volume":"280","author":"Schattenberg","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2023.e15347_bib42","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/0006-2952(89)90338-9","article-title":"Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1)","volume":"38","author":"Ekstr\u00f6m","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib43","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v20.i34.12082","article-title":"Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic","volume":"20","author":"Hassan","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.nutr.21.1.193","article-title":"Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system","volume":"21","author":"Reddy","year":"2001","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.heliyon.2023.e15347_bib45","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.2174\/13816128113199990344","article-title":"Pathophysiology of NASH: perspectives for a targeted treatment","volume":"19","author":"Marra","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.heliyon.2023.e15347_bib46","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3748\/wjg.v11.i9.1392","article-title":"Effect of Sinai San decoction on the development of non-alcoholic steatohepatitis in rats","volume":"11","author":"Zhang","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/810369","article-title":"Hugan qingzhi exerts anti-inflammatory effects in a rat model of nonalcoholic fatty liver disease","author":"Tang","year":"2015","journal-title":"Evidence-Based Complementary Altern. Med."},{"key":"10.1016\/j.heliyon.2023.e15347_bib48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semcdb.2020.04.011","article-title":"Hepatic lipid droplet homeostasis and fatty liver disease","volume":"108","author":"Seebacher","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib49","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent insights into the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib50","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2023.e15347_bib51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41575-019-0239-2","article-title":"What's new in NAFLD pathogenesis, biomarkers and treatment?","volume":"17","author":"Byrne","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib52","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: from new variants to the clinic","volume":"72","author":"Tr\u00e9po","year":"2020","journal-title":"H Hepatol"},{"key":"10.1016\/j.heliyon.2023.e15347_bib53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","article-title":"Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology","volume":"17","author":"Eslam","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib54","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/ijms19030911","article-title":"Genetic and epigenetic regulation in nonalcoholic fatty liver disease (NAFLD)","volume":"19","author":"Del Campo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e15347_bib55","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib56","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2023.e15347_bib57","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/00365520902845268","article-title":"Metformin in patients with nonalcoholic fatty liver disease: a randomized, controlled trial","volume":"44","author":"Haukeland","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib58","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/gast.2002.33666","article-title":"Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro","volume":"122","author":"Galli","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.heliyon.2023.e15347_bib59","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1128\/MCB.16.7.3410","article-title":"Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: regulation by peroxisome proliferator-activated receptor gamma","volume":"16","author":"Sears","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/ajg.2010.299","article-title":"Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial","volume":"106","author":"Foster","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib61","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0140-6736(10)61272-X","article-title":"Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis","volume":"376","author":"Athyros","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2023.e15347_bib62","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2023.e15347_bib63","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e15347_bib64","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/hep.20092","article-title":"Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial","volume":"39","author":"Lindor","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2023.e15347_bib65","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/j.gastro.2014.04.046","article-title":"No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial","volume":"147","author":"Sanyal","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.heliyon.2023.e15347_bib66","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/hep.22668","article-title":"Nuclear bile acid receptor farnesoid X receptor meets nuclear factor-kappaB: new insights into hepatic inflammation","volume":"48","author":"Wagner","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2023.e15347_bib67","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3892\/ijmm.2013.1503","article-title":"Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study","volume":"32","author":"Sakata","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.heliyon.2023.e15347_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700483","article-title":"Potential biological effects of (\u2212)-Epigallocatechin-3-gallate on the treatment of nonalcoholic fatty liver disease","volume":"62","author":"Chen","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.heliyon.2023.e15347_bib69","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jfca.2004.06.008","article-title":"(+)-Catechin and (\u2212)-epicatechin in Bulgarian fruits","volume":"18","author":"Tsanova-Savova","year":"2005","journal-title":"J. Food Compos. Anal."},{"key":"10.1016\/j.heliyon.2023.e15347_bib70","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1515\/jbcpp-2021-0285","article-title":"Is it possible to treat nonalcoholic liver disease using a flavanol-based nutraceutical approach? Basic and clinical data","volume":"33","author":"Hidalgo","year":"2022","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700303","article-title":"\u2010Epicatechin regulates blood lipids and attenuates hepatic steatosis in rats fed high\u2010fat diet","volume":"61","author":"Cheng","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.heliyon.2023.e15347_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2019.108296","article-title":"Effects of (\u2212)-epicatechin on the time course of the expression of perilipins in a diet-induced model of nonalcoholic steatohepatitis","volume":"77","author":"Hidalgo","year":"2020","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.heliyon.2023.e15347_bib73","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1248\/bpb.b16-00942","article-title":"Therapeutic effect of gypenosides on nonalcoholic steatohepatitis via regulating hepatic lipogenesis and fatty acid oxidation","volume":"40","author":"Li","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.heliyon.2023.e15347_bib74","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.phymed.2016.08.003","article-title":"The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats","volume":"23","author":"Lin","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.heliyon.2023.e15347_bib75","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/768540","article-title":"Treatment of nonalcoholic fatty liver disease with total alkaloids in rubus aleaefolius poir through regulation of fat metabolism","author":"Li","year":"2014","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"10.1016\/j.heliyon.2023.e15347_bib76","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cmet.2008.10.008","article-title":"Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance","volume":"8","author":"Radhakrishnan","year":"2008","journal-title":"Cell Metabol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib77","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1017\/S0007114520000495","article-title":"Combined effect of n-3 fatty acids and phytosterol esters on alleviating hepatic steatosis in non-alcoholic fatty liver disease subjects: a double-blind placebo-controlled clinical trial","volume":"123","author":"Song","year":"2020","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.heliyon.2023.e15347_bib78","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/jmf.2019.0120","article-title":"\u03b2-Sitosterol shows potential to protect against the development of high-fructose diet-induced metabolic dysfunction in female rats","volume":"23","author":"Gumede","year":"2020","journal-title":"J. Med. Food"},{"key":"10.1016\/j.heliyon.2023.e15347_bib79","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1021\/jf030081t","article-title":"Antho-cyanin and proanthocyanidin content in selected white and red wines. Oxygen radical absorbance capacity comparison with nontraditional wines obtained from highbush blueberry","volume":"51","author":"Sanchez-Moreno","year":"2003","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.heliyon.2023.e15347_bib80","first-page":"479","article-title":"Grape seed procyanidins improve atherosclerotic risk index and induce liver CYP7A1 and SHP expression in healthy rats","volume":"19","author":"Del Bas","year":"2005","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J."},{"key":"10.1016\/j.heliyon.2023.e15347_bib81","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.ypmed.2011.12.018","article-title":"Isoflavones as a smart curer for non-alcoholic fatty liver disease and pathological adiposity via ChREBP and Wnt signaling","volume":"54","author":"Kim","year":"2012","journal-title":"Prev. Med."},{"key":"10.1016\/j.heliyon.2023.e15347_bib82","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jn\/137.5.1127","article-title":"Genistein downregulates SREBP-1 regulated gene expression by inhibiting site-1 protease expression in HepG2 cells","volume":"137","author":"Eui","year":"2007","journal-title":"J. Nutr."},{"key":"10.1016\/j.heliyon.2023.e15347_bib83","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1021\/acs.jafc.8b01691","article-title":"Genistein ameliorates non-alcoholic fatty liver disease by targeting the thromboxane A2 pathway","volume":"66","author":"Wang","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.heliyon.2023.e15347_bib84","first-page":"201","article-title":"Rutin content in plant products","volume":"44","author":"Atanassova","year":"2009","journal-title":"J. Chem. Technol. Metall."},{"key":"10.1016\/j.heliyon.2023.e15347_bib85","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12161-016-0552-0","article-title":"Simultaneous determination of quercetin, rutin, naringin, and naringenin in different fruits by capillary zone electrophoresis","volume":"10","author":"Memon","year":"2017","journal-title":"Food Anal. Methods"},{"key":"10.1016\/j.heliyon.2023.e15347_bib86","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jsps.2016.04.025","article-title":"The pharmacological potential of rutin","volume":"25","author":"Ganeshpurkar","year":"2017","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.heliyon.2023.e15347_bib87","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.numecd.2018.12.001","article-title":"Betulinic acid inhibits high-fat diet-induced obesity and improves energy balance by activating AMPK","volume":"29","author":"Kim","year":"2019","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.heliyon.2023.e15347_bib88","article-title":"Pharmacological activities of alisma orientale against nonalcoholic fatty liver disease and metabolic syndrome: literature review, evid. Based complement","author":"Choi","year":"2019","journal-title":"Alternative Med."},{"key":"10.1016\/j.heliyon.2023.e15347_bib89","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.3390\/ijms20081984","article-title":"Lipid modulating anti-oxidant stress activity of gastrodin on nonalcoholic fatty liver disease larval zebrafish model","volume":"20","author":"Ahmad","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e15347_bib90","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5763602","article-title":"Recent advances in the pharmacological activities of dioscin","author":"Yang","year":"2019","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.heliyon.2023.e15347_bib91","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.lfs.2017.11.027","article-title":"Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice","volume":"192","author":"Zhang","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2023.e15347_bib92","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/ijms18030620","article-title":"A biomedical investigation of the hepatoprotective effect of radix salviae miltiorrhizae and network pharmacology-based prediction of the active compounds and molecular targets","volume":"18","author":"Hong","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e15347_bib93","doi-asserted-by":"crossref","first-page":"11245","DOI":"10.1073\/pnas.0404297101","article-title":"Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver","volume":"101","author":"Chen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.heliyon.2023.e15347_bib94","doi-asserted-by":"crossref","first-page":"13710","DOI":"10.1073\/pnas.231370798","article-title":"Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation\/dephosphorylation of the carbohydrate response element binding protein","volume":"98","author":"Kawaguchi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.heliyon.2023.e15347_bib95","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2337\/db06-0200","article-title":"Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob\/ob","volume":"55","author":"Dentin","year":"2006","journal-title":"Mice Diabetes"},{"key":"10.1016\/j.heliyon.2023.e15347_bib96","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/jn\/131.5.1438","article-title":"Dietary fat and garlic oil independently regulate hepatic cytochrome p(450) 2B1 and the placental form of glutathione S-transferase expression in rats","volume":"131","author":"Chen","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.heliyon.2023.e15347_bib97","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2337\/db09-0634","article-title":"Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance","volume":"58","author":"Mulvihill","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.heliyon.2023.e15347_bib98","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jgr.2014.11.004","article-title":"Ginsenoside Rb1 ameliorates liver fat accumulation by upregulating perilipin expression in adipose tissue of db\/db obese mice","volume":"39","author":"Yu","year":"2015","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.heliyon.2023.e15347_bib99","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/nu10010020","article-title":"Leonurus japonicus houtt attenuates nonalcoholic fatty liver disease in free fatty acid-induced HepG2 cells and mice fed a high-fat diet","volume":"10","author":"Lee","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2023.e15347_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201600889","article-title":"Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in dietinduced obesity","volume":"61","author":"Kim","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.heliyon.2023.e15347_bib101","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4589810","article-title":"Jwa kum whan attenuates nonalcoholic fatty liver disease by modulating glucose metabolism and the insulin signaling pathway","author":"Lim","year":"2019","journal-title":"Evid. Based Complement Alternat. Med."},{"key":"10.1016\/j.heliyon.2023.e15347_bib102","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1043-4526(06)51002-2","volume":"51","author":"Rao","year":"2006","journal-title":"Adv. Food Nutr. Res."},{"key":"10.1016\/j.heliyon.2023.e15347_bib103","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.26319","article-title":"Intestinal microbiota in patients with nonalcoholic fatty liver disease","volume":"58","author":"Mouzaki","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2023.e15347_bib104","doi-asserted-by":"crossref","first-page":"257S","DOI":"10.1093\/jn\/134.1.257S","article-title":"Carotenoid action on the immune response","volume":"134","author":"Chew","year":"2004","journal-title":"J. Nutr."},{"key":"10.1016\/j.heliyon.2023.e15347_bib105","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.mcg.0000212608.59090.08","article-title":"Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD)","volume":"40","author":"Madan","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib106","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1478-3231.2005.01126.x","article-title":"Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease","volume":"25","author":"Perlemuter","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.heliyon.2023.e15347_bib107","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.taap.2011.04.005","article-title":"Comparative gene expression profiles induced by PPAR\u03b3 and PPAR\u03b1\/\u03b3 agonists in rat hepatocytes","volume":"254","author":"Rogue","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib108","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/2047-783X-16-2-76","article-title":"Plasma levels of vitamin e and carotenoids are decreased in patients with nonalcoholic steatohepatitis (nash)","volume":"16","author":"Erhardt","year":"2011","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.heliyon.2023.e15347_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-1004-0","article-title":"Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway","volume":"9","author":"Qiu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2023.e15347_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172715","article-title":"Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy","volume":"864","author":"Yu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106195","article-title":"Baicalin attenuates hepatic injury in non-alcoholic steatohepatitis cell model by suppressing inflammasome-dependent GSDMD-mediated cell pyroptosis","volume":"81","author":"Shi","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.heliyon.2023.e15347_bib112","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2023.e15347_bib113","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib114","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2017.11.040","article-title":"Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice","volume":"68","author":"Xu","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ph12010011","article-title":"The therapeutic potential of naringenin: a review of clinical trials","volume":"12","author":"Salehi","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.heliyon.2023.e15347_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120752","article-title":"Naringenin: a potential flavonoid phytochemical for cancer therapy","volume":"305","author":"Motallebi","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2023.e15347_bib117","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/advances\/nmaa106","article-title":"A comprehensive systematic review of the effects of naringenin, a citrus-derived flavonoid, on risk factors for nonalcoholic fatty liver disease","volume":"12","author":"Naeini","year":"2021","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.heliyon.2023.e15347_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119487","article-title":"Naringin improves lipid metabolism in a tissue-engineered liver model of NAFLD and the underlying mechanisms","volume":"277","author":"Zhang","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2023.e15347_bib119","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/bph.14938","article-title":"Naringenin attenuates non\u2010alcoholic fatty liver disease by down\u2010regulating the NLRP3\/NF\u2010\u03baB pathway in mice","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib120","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s11095-010-0089-7","article-title":"Apigenin: a promising molecule for cancer prevention","volume":"27","author":"Shukla","year":"2010","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.heliyon.2023.e15347_bib121","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1021\/jf000892m","article-title":"Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants","volume":"49","author":"Miean","year":"2001","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.heliyon.2023.e15347_bib122","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/10942912.2016.1207188","article-title":"Health functionality of apigenin: a review","volume":"20","author":"Ali","year":"2016","journal-title":"Int. J. Food Prop."},{"key":"10.1016\/j.heliyon.2023.e15347_bib123","first-page":"1","article-title":"Recent advances in the pharmacological actions of apigenin, its complexes, and its derivatives","author":"Li","year":"2022","journal-title":"Food Rev. Int."},{"key":"10.1016\/j.heliyon.2023.e15347_bib124","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1007\/s10753-020-01238-5","article-title":"Hepatoprotective effect of apigenin against liver injury via the non-canonical NF-\u03baB pathway in vivo and in vitro","volume":"43","author":"Yue","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.heliyon.2023.e15347_bib125","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jnutbio.2019.05.015","article-title":"Apigenin ameliorates HFD-induced NAFLD through regulation of the XO\/NLRP3 pathways","volume":"71","author":"Lv","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.heliyon.2023.e15347_bib126","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/molecules21091264","article-title":"Cyanidin-3-O-glucoside: physical-chemistry, foodomics and health effects","volume":"21","author":"Olivas-Aguirre","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2023.e15347_bib127","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1089\/jmf.2011.1806","article-title":"Cyanidin-3-Glucoside-Rich extract from Chinese bayberry fruit protects pancreatic \u03b2 cells and ameliorates hyperglycemia in streptozotocin-induced diabetic mice","volume":"15","author":"Sun","year":"2012","journal-title":"J. Med. Food"},{"key":"10.1016\/j.heliyon.2023.e15347_bib128","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3892\/ijmm.2014.2013","article-title":"Cyanidin-3-glucoside isolated from mulberry fruit protects pancreatic \u03b2-cells against oxidative stress-induced apoptosis","volume":"35","author":"Lee","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.heliyon.2023.e15347_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113128","article-title":"The anticancer effects of cyanidin 3-O-glucoside combined with 5-fluorouracil on lung large-cell carcinoma in nude mice","volume":"151","author":"Wu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2023.e15347_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116212","article-title":"Cyanidin-3-O-glucoside impacts fecal discharge of polystyrene microplastics in mice: potential role of microbiota-derived metabolites","volume":"453","author":"Chen","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib131","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1139\/cjpp-2020-0341","article-title":"Cyanidin-3-O-glucoside attenuates high glucose\u2013induced podocyte dysfunction by inhibiting apoptosis and promoting autophagy via activation of SIRT1\/AMPK pathway","volume":"99","author":"Wang","year":"2021","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib132","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1111\/bph.15083","article-title":"Cyanidin\u20103\u2010 O \u2010glucoside improves non\u2010alcoholic fatty liver disease by promoting PINK1\u2010mediated mitophagy in mice","volume":"177","author":"Li","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib133","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.freeradbiomed.2020.08.006","article-title":"Cyanidin-3-O-\u03b2-glucoside inactivates NLRP3 inflammasome and alleviates alcoholic steatohepatitis via SirT1\/NF-\u03baB signaling pathway","volume":"160","author":"Zhou","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.heliyon.2023.e15347_bib134","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3390\/nu8070396","article-title":"Mangiferin and cancer: mechanisms of action","volume":"8","author":"Gold-Smith","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2023.e15347_bib135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/138955712800493870","article-title":"Perspectives on medicinal properties of mangiferin","volume":"12","author":"Vyas","year":"2012","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e15347_bib136","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1078\/0944-7113-00009","article-title":"Antidiabetic activity of a xanthone compound, mangiferin","volume":"8","author":"Miura","year":"2001","journal-title":"Phytomedicine"},{"key":"10.1016\/j.heliyon.2023.e15347_bib137","doi-asserted-by":"crossref","first-page":"8837","DOI":"10.1039\/D0FO01436B","article-title":"Mangiferin protects against alcoholic liver injury via suppression of inflammation-induced adipose hyperlipolysis","volume":"11","author":"Dong","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.heliyon.2023.e15347_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/4084566","article-title":"Mangiferin ameliorates HFD-induced NAFLD through regulation of the AMPK and NLRP3 inflammasome signal pathways","volume":"2021","author":"Yong","year":"2021","journal-title":"J. Immunol Res."},{"key":"10.1016\/j.heliyon.2023.e15347_bib139","article-title":"Bioactive compounds of oils extracted from fruits seeds obtained from agroindustrial waste","volume":"119","author":"da Silva","year":"2016","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib140","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/17474124.2019.1634544","article-title":"Olive oil antioxidants and non-alcoholic fatty liver disease","volume":"13","author":"Abenavoli","year":"2019","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e15347_bib141","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jsps.2021.09.014","article-title":"Cold-pressed raspberry seeds oil ameliorates high-fat diet triggered non-alcoholic fatty liver disease","volume":"29","author":"Hendawy","year":"2021","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.heliyon.2023.e15347_bib142","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1017\/S0007114520000318","article-title":"Flaxseed oil in the context of a weight loss programme ameliorates fatty liver grade in patients with non-alcoholic fatty liver disease: a randomised double-blind controlled trial","volume":"123","author":"Rezaei","year":"2020","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.heliyon.2023.e15347_bib143","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/foods10123022","article-title":"The regulatory effects of citrus peel powder on liver metabolites and gut flora in mice with non-alcoholic fatty liver disease (NAFLD)","volume":"10","author":"Hu","year":"2021","journal-title":"Foods"},{"key":"10.1016\/j.heliyon.2023.e15347_bib144","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3746\/pnf.2016.21.1.14","article-title":"Ameliorative effects of pomegranate peel extract against dietary-induced nonalcoholic fatty liver in rats","volume":"21","author":"Al-Shaaibi","year":"2016","journal-title":"Prev. Nutr. Food Sci."},{"key":"10.1016\/j.heliyon.2023.e15347_bib145","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/jsfa.11535","article-title":"Pomegranate fruit pulp polyphenols reduce diet\u2010induced obesity with modulation of gut microbiota in mice","volume":"102","author":"Song","year":"2021","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.heliyon.2023.e15347_bib146","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jssas.2017.06.002","article-title":"Effect of Litchi chinensis on adipose and hepatic tissues in rats with obesity and non-alcoholic fatty liver disease (NAFLD)","volume":"18","author":"Alexander-Aguilera","year":"2019","journal-title":"J. Saudi Soc. Agric. Sci."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023025549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023025549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:22:20Z","timestamp":1778599340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023025549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":146,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2405844023025549"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15347","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of bioactive phytoconstituents found in fruits in the treatment of non-alcoholic fatty liver disease: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e15347"}}